AI designs viable bacteriophages – innovation and risk

Artificial intelligence has set new standards in biology. Researchers from Stanford University and Arc Institute have used AI to design viable viral genomes. These bacteriophages, viruses that attack bacteria, could be a promising strategy against resistant germs. The designs were tested in laboratory conditions and demonstrated a high ability to kill bacteria without damaging human cells. This could revolutionise the development of new antibiotics and help combat increasing antibiotic resistance. At the same time, research warns of the potential risks associated with the targeted manipulation of genomes. The ability to design viable viruses, if used incorrectly, could lead to unexpected biological effects that are difficult to predict. It is therefore crucial that such technologies are carefully monitored and used ethically. The research also highlights the need to develop security measures to minimise risks while reaping the benefits of AI-enabled innovation. In the future, the combination of AI and biotechnology could lead to groundbreaking discoveries that change not only medicine but also other areas of science.